Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sarana Menara Nusantara Tbk. (TOWR) Price & Performance

Organon Pharma Indonesia Tbk.Trade
Sarana Menara Nusantara Tbk.Trade

Price performance (Past 24H)

Key statistics

Organon Pharma Indonesia Tbk. vs Sarana Menara Nusantara Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sarana Menara Nusantara Tbk. trades at Rp454 (market cap 27.07T, 48.95M 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 259.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

SCPITOWR
Market Cap
104.4B27.07T
Volume
48.95M
Lot
489.54K
Turnover
22.1B
Average Price
451.36
Value
22.1B
Indicative Equilibrium Price
454
Indicative Equilibrium Volume
12.16K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details
TOWR
View details

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI

About Sarana Menara Nusantara Tbk.

PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering

Read more on TOWR